Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biovaccines Nigeria is a public-private partnership between the Federal Government of Nigeria and May & Baker Nigeria PLC, established to revive domestic vaccine production. The company focuses on the development, manufacturing, and distribution of essential vaccines to support Nigeria's National Programme on Immunization. Its primary goal is to ensure national health security by reducing dependence on imported vaccines for diseases such as Yellow Fever, Hepatitis B, and Tetanus. Biovaccines Nigeria operates out of a facility in Yaba, Lagos, and is currently engaged in technology transfer agreements with international partners to localize production capabilities. The company aims to become a hub for vaccine manufacturing in the West African sub-region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biovaccines Nigeria.